A Stanford-led study finds that remnants of an ancient viral infection may be the reason humans and other primates evolved to have larger hearts and bodies.
Eldrin Lewis, Stanford's chief of cardiovascular medicine, opens up about racism and his hopes for future generations of Black physicians and patients.
The COVID-19 pandemic kept a young patient's family from being by her side following her heart transplant. But they found a way to show their love.
Hospitals are seeing a 40% drop in emergency visits, in part because patients with serious conditions other than COVID-19 are reluctant to seek care.
College student Bea White writes about her pacemaker-implant surgery, and how her life has changed since having the procedure.
At 19, Bea White learned she needed a pacemaker to speed up her heart, which beat too slowly because of a condition called heart block.
Researchers are using artificial intelligence to detect abnormalities in the heart through an algorithm that assesses the rate that a heart pumps blood.
A Stanford physician and leader at the American Heart Association explains why the organization's goals for 2030 include more than heart health.
The care Bethel Tan received at Stanford Hospital after surgery to treat moyamoya disease inspired her to pursue a career in nursing.
Stanford research shows that having high blood pressure at peak exercise intensity could indicate good fitness, rather than revealing heart disease risk.
In the final installment of the Demystifying Heart Failure series, physician Randall Stafford and graduate student Min Joo Kim explain how heart failure can be treated and managed.
In this seventh post in the Demystifying Heart Failure series, physician Randall Stafford and graduate student Min Joo Kim outline key medications.
This post, the sixth in the series, examines the benefits of activity for heart failure patients and provides some suggestions for exercising safely.
This installment in the Demystifying Heart Failure series provides dietary guidance for those with heart failure as well as for those hoping to prevent it.
In the fourth post in the Demystifying Heart Failure series, physician Randall Stafford and colleagues explain why the condition develops.
Scientists at Stanford use a gene therapy technique, called RNA silencing, to treat a heart condition called restrictive cardiomyopathy in mice.